Heterodimeric DNA methyltransferases as a platform for creating designer zinc finger methyltransferases for targeted DNA methylation in cells

The ability to target methylation to specific genomic sites would further the study of DNA methylation’s biological role and potentially offer a tool for silencing gene expression and for treating diseases involving abnormal hypomethylation. The end-to-end fusion of DNA methyltransferases to zinc fingers has been shown to bias methylation to desired regions. However, the strategy is inherently limited because the methyltransferase domain remains active regardless of whether the zinc finger domain is bound at its cognate site and can methylate non-target sites. We demonstrate an alternative strategy in which fragments of a DNA methyltransferase, compromised in their ability to methylate DNA, are fused to two zinc fingers designed to bind 9 bp sites flanking a methylation target site. Using the naturally heterodimeric DNA methyltransferase M.EcoHK31I, which methylates the inner cytosine of 5′-YGGCCR-3′, we demonstrate that this strategy can yield a methyltransferase capable of significant levels of methylation at the target site with undetectable levels of methylation at non-target sites in Escherichia coli. However, some non-target methylation could be detected at higher expression levels of the zinc finger methyltransferase indicating that further improvements will be necessary to attain the desired exclusive target specificity.

[1]  Kai-Fai Lee,et al.  A bacterial methyltransferase M.EcoHK311 requires two proteins for in vitro methylation , 1995, Nucleic Acids Res..

[2]  S. Chandrasegaran,et al.  Protein fragment complementation in M.HhaI DNA methyltransferase. , 2005, Biochemical and biophysical research communications.

[3]  M. Minczuk,et al.  Sequence-specific modification of mitochondrial DNA using a chimeric zinc finger methylase , 2006, Proceedings of the National Academy of Sciences.

[4]  Albert Jeltsch,et al.  Chimeric DNA methyltransferases target DNA methylation to specific DNA sequences and repress expression of target genes , 2006, Nucleic acids research.

[5]  A. Kiss,et al.  Functional Reassembly of Split Enzymes On‐Site: A Novel Approach for Highly Sequence‐Specific Targeted DNA Methylation , 2008, Chembiochem : a European journal of chemical biology.

[6]  A. Bird,et al.  DNA methylation landscapes: provocative insights from epigenomics , 2008, Nature Reviews Genetics.

[7]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[8]  S. Chandrasegaran,et al.  Design, engineering, and characterization of zinc finger nucleases. , 2005, Biochemical and biophysical research communications.

[9]  T. Bestor,et al.  Cytosine methylation targetted to pre-determined sequences , 1997, Nature Genetics.

[10]  S. Henikoff,et al.  Identification of in vivo DNA targets of chromatin proteins using tethered Dam methyltransferase , 2000, Nature Biotechnology.

[11]  Kai-Fai Lee,et al.  Functional studies of the small subunit of EcoHK31I DNA methyltransferase , 2006, Biological chemistry.

[12]  S. Kouidou,et al.  Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma. , 2005, Lung cancer.

[13]  J. Zierath,et al.  Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. , 2009, Cell metabolism.

[14]  Alexander Smith,et al.  Specific targeting of cytosine methylation to DNA sequences in vivo , 2006, Nucleic acids research.

[15]  Tony Kouzarides,et al.  Heritable Gene Repression through the Action of a Directed DNA Methyltransferase at a Chromosomal Locus* , 2008, Journal of Biological Chemistry.

[16]  Wataru Nomura,et al.  In vivo site-specific DNA methylation with a designed sequence-enabled DNA methylase. , 2007, Journal of the American Chemical Society.

[17]  A. Vallée-Bélisle,et al.  Detection of protein-protein interactions by protein fragment complementation strategies. , 2000, Methods in enzymology.

[18]  A. Bird,et al.  Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Deng,et al.  Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression , 2001, Oncogene.

[20]  Archana Dhasarathy,et al.  Targeted cytosine methylation for in vivo detection of protein–DNA interactions , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  N. Brown,et al.  Isolation and characterization of the M.EaeI modification methylase. , 1986, The Biochemical journal.

[22]  S. Chandrasegaran,et al.  An engineered split M.HhaI-zinc finger fusion lacks the intended methyltransferase specificity. , 2008, Biochemical and biophysical research communications.

[23]  C. Plass,et al.  Methylation of Adjacent CpG Sites Affects Sp1/Sp3 Binding and Activity in the p21Cip1 Promoter , 2003, Molecular and Cellular Biology.

[24]  P. J. Hurd,et al.  Characterisation of site-biased DNA methyltransferases: specificity, affinity and subsite relationships. , 2002, Nucleic acids research.

[25]  M. Kladde,et al.  Site-selective in vivo targeting of cytosine-5 DNA methylation by zinc-finger proteins. , 2003, Nucleic acids research.